| Patent application number | Description | Published |
|---|
| 20080269277 | Pyrrolopyridine-2-Carboxylic Acid Hydrazides - Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth. | 10-30-2008 |
| 20080312281 | G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes - Compounds of formula (I), or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes. | 12-18-2008 |
| 20090023703 | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase - Compounds represented by Formula (I): | 01-22-2009 |
| 20090099176 | PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES - Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants. | 04-16-2009 |
| 20090099227 | G-Protein Coupled Receptor Agonists - Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes. | 04-16-2009 |
| 20090221644 | Gpcr Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 09-03-2009 |
| 20090221645 | Dihydroimidazothiazole Derivatives - Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT | 09-03-2009 |
| 20090281060 | HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS - Compounds of Formula (I), R | 11-12-2009 |
| 20090298745 | Treatment of Diabetes with Glycogen Phosphorylase Inhibitors - The invention provides a method of treatment of diabetes, particularly type II diabetes, or a diabetes related condition, comprising night time dosing of an inhibitor of glycogen phosphorylase, optionally in combination another anti-diabetic therapy. | 12-03-2009 |
| 20100035897 | Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists - Compounds of formula (I): R | 02-11-2010 |
